Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Charlotte Touzalin
Person

Charlotte Touzalin

Tracked across 1 events · 12 articles · First seen Aug 15, 2026 · Last active Aug 15, 2026

Sentiment
80
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 80
Tech
GLP-1 drugs show promise for PMOS
A small but growing body of research indicates that GLP-1 drugs, commonly used for obesity and diabetes, may also be effective in treating polyendocrine metabolic ovarian syndrome (PMOS), a hormonal disorder affecting 1 in 8…
Impact: Patient who participated in the PMOS trial, experienced significant symptom improvement and weight loss, but lost access to the drug after the study ended due to insurance issues.
Aug 15, 2026 · 12 articles
Key Actions (1)
60 Charlotte Touzalin participated in trialGLP-1 drugs show promise for PMOS
ERGEN INTELLIGENCE
Track Charlotte Touzalin live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.